Bisantrene for Relapsed /Refractory AML

Clinical trial NCT03820908 · COMPLETED

Trial details

NCT number: NCT03820908
Sponsor: Sheba Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Allogeneic Stem Cell Transplantation

Start date: 2019-07-18
Primary completion: 2020-05-19
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.